menu
    • menu
    [{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"Dopamine receptor","graph1":"Neurology","graph2":"Approved FDF","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bened Biomedical \/ Undisclosed"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum","moa":"Dopamine receptor","graph1":"Neurology","graph2":"Approved FDF","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bened Biomedical \/ Undisclosed"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"PS128","moa":"Dopamine receptor","graph1":"Neurology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"TAIWAN","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"PS128","moa":"Dopamine receptor","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"TAIWAN","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"PS128","moa":"Dopamine receptor","graph1":"Sleep","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"TAIWAN","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"PS128","moa":"Dopamine receptor","graph1":"Neurology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"TAIWAN","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"TAIWAN","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Neurology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"TAIWAN","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"TAIWAN","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Neuralli MP","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"TAIWAN","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"PS150","moa":"Undisclosed","graph1":"Sleep","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"TAIWAN","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"PS23","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Bened Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"TAIWAN","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"PS23 Live","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Bened Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Bened Biomedical"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Lacticaseibacillus Paracasei","moa":"Microbiome","graph1":"Neurology","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Undisclosed"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Chi-Chang Huang","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"CHINA","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bened Biomedical \/ Chi-Chang Huang","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Chi-Chang Huang"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Chi-Chang Huang","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"CHINA","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Limosilactobacillus Fermentum","moa":"Undisclosed","graph1":"Sleep","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bened Biomedical \/ Chi-Chang Huang","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Chi-Chang Huang"},{"orgOrder":0,"company":"Bened Biomedical","sponsor":"Chi-Chang Huang","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"CHINA","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"PS23","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Bened Biomedical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bened Biomedical \/ Chi-Chang Huang","highestDevelopmentStatusID":"1","companyTruncated":"Bened Biomedical \/ Chi-Chang Huang"}]

    Find Clinical Drug Pipeline Developments & Deals by Bened Biomedical

    Menu

    Bened Biomedical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lacticaseibacillus Paracasei

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition

                            Details : Lacticaseibacillus Paracasei is a Probiotic drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Cognitive Dysfunction.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            September 11, 2025

                            Lead Product(s) : Lacticaseibacillus Paracasei

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Neuralli MP

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Recipient : Mackay Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Neuralli® MP on Self-Defined Outcomes in Adults with Autistic Traits

                            Details : Neuralli MP is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Autism Spectrum Disorder.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 14, 2025

                            Lead Product(s) : Neuralli MP

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Recipient : Mackay Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Limosilactobacillus Fermentum

                            Therapeutic Area : Sleep

                            Study Phase : Undisclosed

                            Sponsor : Chi-Chang Huang

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluating the Potential of Probiotic Supplementation Sleep Quality

                            Details : Limosilactobacillus Fermentum is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Wake Disorders.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            July 03, 2024

                            Lead Product(s) : Limosilactobacillus Fermentum

                            Therapeutic Area : Sleep

                            Highest Development Status : Undisclosed

                            Sponsor : Chi-Chang Huang

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Undisclosed

                            Recipient : National Taiwan Sport University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Exploring the Effects of Probiotics on Workplace Related Stress Symptoms

                            Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress Disorders, Traumatic.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            April 24, 2024

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Undisclosed

                            Recipient : National Taiwan Sport University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PS150

                            Therapeutic Area : Sleep

                            Study Phase : Undisclosed

                            Recipient : National Yang Ming Chiao Tung University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy Assessment of Probiotics in Improving Sleep Indices

                            Details : PS150 is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Initiation and Maintenance Disorders.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            April 11, 2024

                            Lead Product(s) : PS150

                            Therapeutic Area : Sleep

                            Highest Development Status : Undisclosed

                            Recipient : National Yang Ming Chiao Tung University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Recipient : Changhua Christian Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Probiotics for Parkinson Disease (PD)

                            Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Parkinson Disease.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            November 07, 2023

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Recipient : Changhua Christian Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Undisclosed

                            Sponsor : Chi-Chang Huang

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

                            Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Muscular Atrophy.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            October 02, 2023

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Undisclosed

                            Sponsor : Chi-Chang Huang

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Undisclosed

                            Recipient : Mackay Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Exploring the Effects of Lactobacillus Paracasei PS23 on Workplace-related Stress Symptoms Among Office Worker...

                            Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress Disorders, Traumatic.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            April 24, 2023

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Undisclosed

                            Recipient : Mackay Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PS23

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Recipient : Mackay Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome

                            Details : PS23 is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Post-Acute COVID-19 Syndrome.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            April 14, 2023

                            Lead Product(s) : PS23

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Recipient : Mackay Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Bened Biomedical

                            China arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PS23

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Undisclosed

                            Sponsor : Chi-Chang Huang

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Lactobacillus Paracasei PS23 on Anti-fatigue

                            Details : PS23 is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Fatigue.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            April 26, 2022

                            Lead Product(s) : PS23

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Undisclosed

                            Sponsor : Chi-Chang Huang

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth